Mice Develop Effective but Delayed Protective Immune Responses When Immunized as Neonates either Intranasally with Nonliving VP6/LT(R192G) or Orally with Live Rhesus Rotavirus Vaccine Candidates
Authors:
- 15 May 2006
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 80 (10) , 4949-61
Abstract
Rotavirus vaccines are delivered early in life, when the immune system is immature. To determine the effects of immaturity on responses to candidate vaccines, neonatal (7 days old) and adult mice were immunized with single doses of eitherEscherichia coli-expressed rotavirus VP6 protein and the adjuvant LT(R192G) or live rhesus rotavirus (RRV), and protection against fecal rotavirus shedding following challenge with the murine rotavirus strain EDIM was determined. Neonatal mice immunized intranasally with VP6/LT(R192G) were unprotected at 10 days postimmunization (dpi) and had no detectable rotavirus B-cell (antibody) or CD4+CD8+T-cell (rotavirus-inducible, Th1 [gamma interferon and interleukin-2 {IL-2}]-, Th2 [IL-5 and IL-4]-, or ThIL-17 [IL-17]-producing spleen cells) responses. However, by 28 and 42 dpi, these mice were significantly (P ≥ 0.003) protected and contained memory rotavirus-specific T cells but produced no rotavirus antibody. In contrast, adult mice were nearly fully protected by 10 dpi and contained both rotavirus immunoglobulin G and memory T cells. Neonates immunized orally with RRV were also less protected (P= 0.01) than adult mice by 10 dpi and produced correspondingly less rotavirus antibody. Both groups contained few rotavirus-specific memory T cells. Protection levels by 28 dpi for neonates or adults were equal, as were rotavirus antibody levels. This report introduces a neonatal mouse model for active protection studies with rotavirus vaccines. It indicates that, with time, neonatal mice develop full protection after intranasal immunization with VP6/LT(R192G) or oral immunization with a live heterologous rotavirus and supports reports that protection depends on CD4+T cells or antibody, respectively.Keywords
This publication has 72 references indexed in Scilit:
- Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae Journal of Experimental Medicine, 2005
- Pulmonary Interleukin-23 Gene Delivery Increases Local T-Cell Immunity and Controls Growth ofMycobacterium tuberculosisin the LungsInfection and Immunity, 2005
- Interleukin-17 Family Members and InflammationImmunity, 2004
- A Rotavirus Vaccine for Prophylaxis of Infants Against Rotavirus GastroenteritisThe Pediatric Infectious Disease Journal, 2004
- Neonatal adaptive immunity comes of ageNature Reviews Immunology, 2004
- Urinary myiasis associated with ureteral stent placementsThe Pediatric Infectious Disease Journal, 2004
- Protection Conferred by Neonatal Rotavirus Infection against Subsequent Rotavirus DiarrheaThe Journal of Infectious Diseases, 1993
- Fecal Antibody Responses to Symptomatic and Asymptomatic Rotavirus InfectionsThe Journal of Infectious Diseases, 1993
- Seroepidemiologic Evaluation of Antibodies to Rotavirus as Correlates of the Risk of Clinically Significant Rotavirus Diarrhea in Rural BangladeshThe Journal of Infectious Diseases, 1992
- Clinical Immunity after Neonatal Rotavirus InfectionNew England Journal of Medicine, 1983